View Document Preview and Link Document Date: 2014-11-06 23:49:22 Open Document File Size: 106,50 KB Share Result on Facebook
City Victoria / / Company MSAC / Consumer Impact Statement There / Victorian Infectious Disease Reference Laboratory / / Country Australia / / Currency USD / / Facility Victorian Infectious Disease Reference Laboratory / / IndustryTerm healthcare workers / health services / agreed clinical protocols / health technology assessments / / MedicalCondition atypical mycobacterial infection / latent tuberculosis infection / TB / infectious bacterial disease / active TB disease / e.g. tumour necrosis factor / chest pain / M. tuberculosis / disease / Mycobacterium tuberculosis / M. tuberculosis complex / chills / latent tuberculosis bacillus infection / active tuberculosis / active TB / fever / persistent cough / active disease / fatigue / latent infection / Latent tuberculosis infections / Tuberculosis / / MedicalTreatment clinical protocols / immunosuppressive therapy / / Organization National Tuberculosis Advisory Committee / National Science Foundation / Department of Health / Australian Health Ministers’ Advisory Council / Medicare / / Person Miriam Paul / / Position Governor / Minister / Executive / / Product isoniazid / / ProvinceOrState Northern Territory / / Technology agreed clinical protocols / / URL www.msac.gov.au / http / SocialTag 
Microsoft Word[removed]PSD final_220512.doc